Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: gout

Treating to Target in Gout: The Trouble with Serum Urate

Samantha C. Shapiro, MD  |  July 21, 2022

New analyses of treat to target in gout may lead to revisions in some guidelines.

Filed under:ConditionsEULAR/OtherGout and Crystalline ArthritisMeeting Reports Tagged with:EULARGoutGout Resource CenterTreat-to-Target

Gout Experts Share Insights Into a Variety of Challenging Gout Scenarios

Ruth Jessen Hickman, MD  |  June 14, 2022

Although the diagnosis and treatment of gout are sometimes straightforward, prac­titioners encounter challenges in patients with atypical presentations, as well as those with medically complex situations or refractory disease. Here, gout experts share insights into some of these scenarios. Flare in Hospitalized Patients When not contraindicated, the 2020 ACR Guideline for the Management of Gout…

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:Flaresorgan transplantpegloticasepolyarticular arthritisrefractory gout

Following two infusions of 1,000 mg rituximab eight weeks apart, the patient’s symptoms resolved.

Gout: Infusion Reactions

Staff  |  May 25, 2022

ACR Image Competition 2021 Results, Part 3: Erosive Polyarticular Tophaceous Gout

Wendy Wan Hui Lee, MD, MRCP(UK); FEATURED IMAGE FROM EAST ASIA & PACIFIC  |  May 12, 2022

Erosive Polyarticular Chronic Tophaceous Gout in a Young Man A 27-year-old man was referred to us for joint pain and nodular swelling over multiple joints. His symptoms started when he was 13 years old, but he was sub-optimally treated. On examination, we found marked digital deformity, with multiple large tophi over the small joints of…

Filed under:Professional Topics Tagged with:biasdiagnostic imagingDiversityhealthcare disparitiesImage CompetitionRacism

Another Way: RheumMadness 2022 DECT in Gout Scouting Report

MedStar Georgetown Washington Hospital Center: Leen Al Saleh, MD; Ajita Acharya, MD; Elena Obreja, MD; & Akrithi U. Garren, MD  |  February 14, 2022

Research has found dual-energy computed tomography (DECT) may be a non-invasive and cost-effective option to help rheumatologists more accurately diagnose gout.

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:AIartificial intelligenceDECTdual-energy computed tomography (DECT)Goutimagingmachine learning

A Quick Reference Guide to Patient Education Materials on Gout

From the College  |  February 11, 2022

The following websites offer an abundance of options to help your patients understand their disease and learn to live with it. Several sites offer information in various languages, and for your patients who prefer audio-visual to print, one site has several educational videos. The ACR—Diseases and Conditions: Gout (Web page or PDF available in English…

Filed under:ConditionsGout and Crystalline ArthritisPresident's Perspective Tagged with:GoutGout Resource Centerpatient education

Gout Management Recommendations from the ACR’s 2020 Guideline

From the College  |  February 11, 2022

The 2020 ACR Guideline for the Management of Gout is intended to provide guidance for the management of patients with gout, and includes recommendations on the indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations.1 The guideline includes 42 recommendations, of which 16 are strong….

Filed under:Clinical Criteria/GuidelinesConditionsGout and Crystalline Arthritis Tagged with:GoutGout Resource Center

Clinical Insights into Gout Management: Q&A with Dr. Tuhina Neogi

Mary Choy, PharmD, BCGP, FASHP  |  February 9, 2022

Gout affects more than 9.2 million adults in the U.S. and is the most common form of inflammatory arthritis. This condition and its complications are painful and potentially disabling with varying risk factors. It is characterized by symptoms that are usually sudden, with intense episodes of painful swelling in one or more joints, most often…

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsDrug UpdatesGout and Crystalline ArthritisMeeting Reports Tagged with:Dr. Tuhina NeogiGoutGout Resource Center

Research on Diet & Gout

Keri Losavio  |  February 9, 2022

According to research from Yokose et al. presented at ACR Convergence 2021, regardless of genetic predisposition, diet influences a person’s risk of developing gout.1 Several recent analyses of the Global Burden of Disease (GBD) Study report a disproportionate worsening of gout burden among women, suggesting intensive dietary measures for gout prevention are indicated, especially in…

Filed under:ACR ConvergenceConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:ACR Convergence – GoutACR Convergence 2021ACR Convergence 2021 – GoutDietGout

Tigulixostat Appears Promising for the Treatment of Gout

Michele B. Kaufman, PharmD, BCGP  |  February 2, 2022

In a phase 2 study, tigulixostat treatment proved safe for lowering serum uric acid (sUA) levels in patients with gout.

Filed under:ACR ConvergenceConditionsDrug UpdatesGout and Crystalline ArthritisMeeting Reports Tagged with:ACR Convergence – GoutACR Convergence 2021ACR Convergence 2021 – GoutGoutserum uric acidtigulixostat

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 59
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences